drugset / Trial / NCT05914896

Hyperosmolality and Acute Kidney Injury After Cardiac Surgery

NCT05914896

Completed 200 enrolled Umeå University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The goal of this randomized controlled trial is to test if a hyperosmolar prime solution used for cardiopulmonary bypass increases the risk for acute postoperative kidney injury.

Timeline

Start
2019-04-24
Primary completion
2020-06-24
Completion
2020-06-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mannitol Diagnostic / imaging agent 60 g
Comparator Ringer acetate Other / unclassified 1000 ml
Comparator sodium chloride Unknown 160 mmol
Comparator Heparin Other / unclassified 10000 iu

Indications